Shareholder plans sale of 20,070 common shares

A shareholder of ABEO plans to sell 20,070 shares of common stock under Rule 144.

Accepted by SEC EDGAR 02/09/2026 - 04:01 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A shareholder of ABEO plans to sell 20,070 shares of common stock under Rule 144. The planned sale, through broker Stifel Nicolaus & Company Inc., has an aggregate market value of $102,168.00 and is listed for execution on or about 02/02/2026 on the Nasdaq.

The seller previously acquired 36,101 shares of common stock on 01/31/2026 via restricted stock units granted as equity compensation by the issuer and paid in equity rather than cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ABEO Rule 144 filing disclose?

The filing discloses that a shareholder plans to sell 20,070 ABEO common shares under Rule 144. The sale is through Stifel Nicolaus & Company Inc. on Nasdaq, with an aggregate market value of $102,168.00 based on the figures in the notice.

How many ABEO shares are planned to be sold and on what exchange?

The shareholder plans to sell 20,070 ABEO common shares on the Nasdaq. The filing lists Stifel Nicolaus & Company Inc. as broker and shows an aggregate market value of $102,168.00 for this planned transaction as of the notice.

How were the ABEO shares in the Rule 144 notice acquired?

The ABEO shares were acquired as restricted stock units granted by the issuer on 01/31/2026. The form shows 36,101 common shares acquired that day, with the nature of payment described as equity compensation instead of a cash purchase.

What is the aggregate market value of ABEO shares to be sold?

The planned sale of 20,070 ABEO common shares has an aggregate market value of $102,168.00. This value comes directly from the Rule 144 securities information table, which also identifies Nasdaq as the trading venue for the transaction.

How many ABEO shares are outstanding according to this notice?

The notice reports 54,191,361 ABEO common shares outstanding. This figure appears in the securities information table and serves as a baseline context for the planned 20,070-share Rule 144 sale listed in the same section of the document.

When is the approximate sale date for the ABEO Rule 144 transaction?

The approximate sale date for the ABEO shares is listed as 02/02/2026. This date appears in the securities information table alongside the 20,070 shares to be sold, the aggregate market value of $102,168.00, and Nasdaq as the named securities exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001772546
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ABEONA THERAPEUTICS INC.
SEC File Number	001-15771
Address of Issuer	6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OHIO 44103
Phone	646-813-4701
Name of Person for Whose Account the Securities are To Be Sold	Silverstein Christine Berni
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	20070	102168.00	54191361	02/02/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/31/2026	Restricted Stock Units	Issuer			36101	01/31/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The shares were sold to cover tax obligations pursuant to an RSA vesting event.
Date of Notice	02/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Luca Lotito, as a duly authorized representative of STIFEL, as attorney-in-fact for Christine Silverstein
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)